Tephrosin has been reported to have anticancer effects by inducing the degradation and internalization of the EGFR in human colon cancer cells [82], suggesting that tephrosin possibly restored paclitaxel sensitivity by inhibiting the EGFR signaling pathway. This evidence concerns the gene EGFR and colonic neoplasm.